Diabetes

Top Story

FDA grants dulaglutide CV indication for diabetes with or without established CVD

FDA grants dulaglutide CV indication for diabetes with or without established CVD
February 24, 2020
In the Journals

Domestic abuse elevates risk for CVD, diabetes, all-cause mortality

February 23, 2020
Women who survived domestic abuse were found to be at greater risk for developing CVD, type 2 diabetes and all-cause mortality compared with women who did not experience…
In the Journals

Greater immature platelet fraction reduces CAD risk, but ‘no difference’ for blood glucose

February 13, 2020
The risk for coronary artery disease may be lower among those with diabetes who have elevated vs. lower immature platelet fraction, although glucose management is…
In the JournalsPerspective

Meta-analysis provides new insights on CV risk with rosiglitazone

February 12, 2020
Rosiglitazone was linked to an increased CV risk, particularly for HF events, in trials with available individual patient-level data, according to a systematic review…
More Headlines »